bioMérieux: Press Releases

Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology
Wednesday, May 26, 2010 by bioMérieux Kyoto, Japan and Marcy l'Etoile, France - 21 May 2010 - Shimadzu and bioMérieux announce today that they have entered into a partnership to commercialise a mass spectrometry system...

bioMérieux and Knome Sign Strategic Partnership
Tuesday, May 04, 2010 by bioMérieux Marcy l'Etoile (France) and Cambridge, Massachusetts (US) - 21 April 2010 - Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics...

Philips and bioMérieux Announce Partnership to Develop and Market Next-Generation Handheld Diagnostic Solutions for Point-of-Care
Friday, January 08, 2010 by bioMérieux Fully automated handheld diagnostic test devices designed to improve diagnosis and disease management in critical care settings within hospitals. Amsterdam, The Netherlands, Marcy...

New A(H1N1) Strain Added to bioMérieux’s Molecular Diagnostic Test NucliSENS EasyQ® Influenza A/B
Tuesday, December 15, 2009 by bioMérieux Marcy l'Etoile, France, 12 November 2009 - A world leader in the field of in vitro diagnostics, bioMérieux has adapted its molecular NucliSENS EasyQ® Influenza A/B test to include the...

bioMérieux Launches a Molecular Diagnostic MRSA Test on its EasyQ® Automated Platform
Monday, November 16, 2009 by bioMérieux Methicillin-resistant Staphylococcus aureus (MRSA) is the most prevalent multi-drug resistant bacteria and a growing threat to health. Marcy l'Etoile, France, 6 November 2009 -...

chromID™ MRSA Launched in US - bioMérieux Adds Methicillin-Resistant Staphylococcus aureus (MRSA) Screening Tool to its Arsenal
Friday, November 06, 2009 by bioMérieux Chromogenic media provides cost-effective MRSA identification for hospitals and labs. Durham, NC (US), 28 October 2009 – bioMérieux, a world leader in the field of in vitro...

2nd World HAI Forum: Experts Discuss Looming Threats to Patient Safety
Wednesday, September 23, 2009 by bioMérieux - Newly evolved enzymes make some bacteria resistant to all common antibiotics - Healthcare workers slow to receive flu vaccines - Countries not doing enough to combat 'superbugs' About...

bioMérieux – Committed to the Fight Against HAI
Monday, September 21, 2009 by bioMérieux bioMérieux, a world leader in the field of in vitro diagnostics (IVD), offers the most comprehensive diagnostic solution on the market to help hospitals and healthcare facilities...